117 related articles for article (PubMed ID: 23713422)
1. Evaluation of RGD peptide hydrogel in the posterior segment of the rabbit eye.
Wang XH; Li S; Liang L; Xu XD; Zhang XZ; Jiang FG
J Biomater Sci Polym Ed; 2013; 24(10):1185-97. PubMed ID: 23713422
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye.
Einmahl S; Savoldelli M; D'Hermies F; Tabatabay C; Gurny R; Behar-Cohen F
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1533-9. PubMed ID: 11980871
[TBL] [Abstract][Full Text] [Related]
3. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
Chen M; Li X; Liu J; Han Y; Cheng L
J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
[TBL] [Abstract][Full Text] [Related]
4. Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes.
Kadam RS; Williams J; Tyagi P; Edelhauser HF; Kompella UB
Mol Vis; 2013; 19():1198-210. PubMed ID: 23734089
[TBL] [Abstract][Full Text] [Related]
5. Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye.
Patel SR; Berezovsky DE; McCarey BE; Zarnitsyn V; Edelhauser HF; Prausnitz MR
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4433-41. PubMed ID: 22669719
[TBL] [Abstract][Full Text] [Related]
6. A Self-Assembling Peptide Gel as a Vitreous Substitute: A Rabbit Study.
Uesugi K; Sakaguchi H; Hayashida Y; Hayashi R; Baba K; Suganuma Y; Yokoi H; Tsujikawa M; Nishida K
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4068-4075. PubMed ID: 28820922
[TBL] [Abstract][Full Text] [Related]
7. Intraocular use of hydrogel tissue adhesive in rabbit eyes.
Sueda J; Fukuchi T; Usumoto N; Okuno T; Arai M; Hirose T
Jpn J Ophthalmol; 2007; 51(2):89-95. PubMed ID: 17401616
[TBL] [Abstract][Full Text] [Related]
8. Drug delivery to the posterior segment of the eye through hydrogel contact lenses.
Schultz C; Breaux J; Schentag J; Morck D
Clin Exp Optom; 2011 Mar; 94(2):212-8. PubMed ID: 21175822
[TBL] [Abstract][Full Text] [Related]
9. Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradation.
Einmahl S; Ponsart S; Bejjani RA; D'Hermies F; Savoldelli M; Heller J; Tabatabay C; Gurny R; Behar-Cohen F
J Biomed Mater Res A; 2003 Oct; 67(1):44-53. PubMed ID: 14517860
[TBL] [Abstract][Full Text] [Related]
10. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
[TBL] [Abstract][Full Text] [Related]
11. Biodegradation of different synthetic hydrogels made of polyethylene glycol hydrogel/RGD-peptide modifications: an immunohistochemical study in rats.
Herten M; Jung RE; Ferrari D; Rothamel D; Golubovic V; Molenberg A; Hämmerle CH; Becker J; Schwarz F
Clin Oral Implants Res; 2009 Feb; 20(2):116-25. PubMed ID: 19077154
[TBL] [Abstract][Full Text] [Related]
12. Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes.
Wang P; Gao Q; Jiang Z; Lin J; Liu Y; Chen J; Zhou L; Li H; Yang Q; Wang T
Clin Exp Ophthalmol; 2012; 40(1):e67-75. PubMed ID: 21883770
[TBL] [Abstract][Full Text] [Related]
13. Injection site and pharmacokinetics after intravitreal injection of immunoglobulin G.
Miura Y; Uematsu M; Teshima M; Suzuma K; Kumagami T; Sasaki H; Kitaoka T
J Ocul Pharmacol Ther; 2011 Feb; 27(1):35-41. PubMed ID: 21182428
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the biocompatibility of novel peptide hydrogel in rabbit eye.
Liang L; Xu XD; Chen CS; Fang JH; Jiang FG; Zhang XZ; Zhuo RX
J Biomed Mater Res B Appl Biomater; 2010 May; 93(2):324-32. PubMed ID: 20225215
[TBL] [Abstract][Full Text] [Related]
15. Intraocular Injection of HyStem Hydrogel Is Tolerated Well in the Rabbit Eye.
Glickman RD; Onorato M; Campos MM; O'Boyle MP; Singh RK; Zarembinski TI; Binette F; Nasonkin IO
J Ocul Pharmacol Ther; 2021; 37(1):60-71. PubMed ID: 33449859
[No Abstract] [Full Text] [Related]
16. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
[TBL] [Abstract][Full Text] [Related]
17. Effect of choroidal perfusion on ocular tissue distribution after intravitreal or suprachoroidal injection in an arterially perfused ex vivo pig eye model.
Abarca EM; Salmon JH; Gilger BC
J Ocul Pharmacol Ther; 2013 Oct; 29(8):715-22. PubMed ID: 23822159
[TBL] [Abstract][Full Text] [Related]
18. Collagenase injection into the suprachoroidal space of the eye to expand drug delivery coverage and increase posterior drug targeting.
Jung JH; Park S; Chae JJ; Prausnitz MR
Exp Eye Res; 2019 Dec; 189():107824. PubMed ID: 31585119
[TBL] [Abstract][Full Text] [Related]
19. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes.
Sakuma T; Tanaka M; Mizota A; Inoue J; Pakola S
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3295-9. PubMed ID: 16123432
[TBL] [Abstract][Full Text] [Related]
20. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
